QQ客服 官方微博 反馈留言

	Overexpression of EphA2, MMP-9, and MVD-CD34 in hepatocellular carcinoma: Implications for tumor progression and prognosis
	Yang, Pu; Yuan, Weijie; He, Jiantai; Wang, Jiwei; Yu, Li; Jin, Xin; Hu, Yu; Liao, Mingmei; Chen, Zihua; Zhang, Yangde*
刊名	Hepatology Research
	2009
卷号	39期号:12页码:1169-1177
关键词	angiogenesis erythropoietin‐producing hepatocellular A2 hepatocellular carcinoma matrix metalloproteinase‐9 prognosis
ISSN号	1872-034X
DOI	10.1111/j.1872-034X.2009.00563.x
URL标识	查看原文
WOS记录号	WOS:000272306100003
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3316308
专题	中南大学
作者单位	1.[Yang, Pu 2.He, Jiantai 3.Zhang, Yangde] Cent S Univ, Hepatobiliary & Enter Surg Res Ctr, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China.
推荐引用方式 GB/T 7714	Yang, Pu,Yuan, Weijie,He, Jiantai,et al. Overexpression of EphA2, MMP-9, and MVD-CD34 in hepatocellular carcinoma: Implications for tumor progression and prognosis[J]. Hepatology Research,2009,39(12):1169-1177.
APA	Yang, Pu.,Yuan, Weijie.,He, Jiantai.,Wang, Jiwei.,Yu, Li.,...&Zhang, Yangde*.(2009).Overexpression of EphA2, MMP-9, and MVD-CD34 in hepatocellular carcinoma: Implications for tumor progression and prognosis.Hepatology Research,39(12),1169-1177.
MLA	Yang, Pu,et al."Overexpression of EphA2, MMP-9, and MVD-CD34 in hepatocellular carcinoma: Implications for tumor progression and prognosis".Hepatology Research 39.12(2009):1169-1177.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。